ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Kansas » Medical Oncology

Top Medical Oncology Prescribers in Kansas

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WILLIAM CATHCARTRAKE M.D.

Medical Oncology

3,604

$440K

166
158 are 65+

9%
patients receiving schedule two controlled substances

Avg: 17%

14%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 17%

$122
Average prescription price

Avg: $226

MARK FESEN MD

Medical Oncology

3,027

$568K

386
332 are 65+

7%
patients receiving schedule two controlled substances

Avg: 17%

12%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 17%

$188
Average prescription price

Avg: $226

SARAH TAYLOR M.D.

Medical Oncology

1,198

$167K

117
72 are 65+

22%
patients receiving schedule two controlled substances

Avg: 17%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 17%

$140
Average prescription price

Avg: $226

JANUARY FIELDS MD

Medical Oncology

1,171

$110K

166
151 are 65+

11%
patients receiving schedule two controlled substances

Avg: 17%

12%
patients receiving schedule three controlled substances

Avg: 11%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 17%

$94
Average prescription price

Avg: $226

DAVID LEE MD

Medical Oncology

948

$525K

139
108 are 65+

8%
patients receiving schedule two controlled substances

Avg: 17%

13%
patients receiving schedule three controlled substances

Avg: 11%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

16%
prescriptions for brand name drugs

Avg: 17%

$554
Average prescription price

Avg: $226

MUHAMMAD AHMED M.D.

Medical Oncology

840

$536K

109
86 are 65+

14%
patients receiving schedule two controlled substances

Avg: 17%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 17%

$638
Average prescription price

Avg: $226

ERIC CARLSON MD

Medical Oncology

819

$114K

132
118 are 65+

8%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 11%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 17%

$139
Average prescription price

Avg: $226

ANNE O'DEA MD

Medical Oncology

793

$101K

128
108 are 65+

9%
patients receiving schedule two controlled substances

Avg: 17%

9%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

8%
prescriptions for brand name drugs

Avg: 17%

$127
Average prescription price

Avg: $226

GREGORY NANNEY MD

Medical Oncology

770

$220K

106
74 are 65+

18%
patients receiving schedule two controlled substances

Avg: 17%

18%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 17%

$285
Average prescription price

Avg: $226

JOAQUINA BARANDA MD

Medical Oncology

695

$351K

102
83 are 65+

42%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 17%

$505
Average prescription price

Avg: $226

STEPHEN WILLIAMSON M.D.

Medical Oncology

608

$220K

89
57 are 65+

40%
patients receiving schedule two controlled substances

Avg: 17%

17%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 17%

$363
Average prescription price

Avg: $226

RENEE BARTLETT MD

Medical Oncology

549

$48.1K

63
45 are 65+

21%
patients receiving schedule two controlled substances

Avg: 17%

0%
patients receiving schedule three controlled substances

Avg: 11%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 17%

$88
Average prescription price

Avg: $226

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank